Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Contemporary Medicine》 2012-07
Add to Favorite Get Latest Update

探讨阿德福韦酯联合双虎清肝颗粒抗肝纤维化指标肝纤四项复常率

Objective Adefovir-Dipivoxil and Shuanghuqinggan granule in the treatment of chronic hepatitis B and liver fibrosis caused by cirrhosis of the liver,in four test results as its important effect on target,explore its recovery rate difference. Methods 45 cases of chronic hepatitis or chronic hepatitis B liver cirrhosis caused the patient,taking Adefovir-Dipivoxil and efficacy of Shuanghuqinggan granule,liver function were observed,virology index,B ultrasound and histological changes of indicators of efficacy,focusing on liver fibrosis four test results change. The control group of 36 patients with the same kind of patients,only taking Adefovir-Dipivoxil l treatment. Results After 6 months after treatment,the treatment group of hepatic fibrosis in four test results before and after the treatment in the variation of different sizes,but there were significant differences(P0.01) ,four Xiang Fu often at the rate of 55% to 75%. But at the same time the control group of patients with various liver fibrosis indexes are improved evidently,but the four indicators of recovery rate is significantly smaller than the treatment group. Conclusion Liver fibrosis four test results of recovery rate for treatment of hepatic fibrosis index,Adefovir-Dipivoxil and Shuanghuqinggan combined treatment group was significantly higher than that of single drug control group,that combined drug therapy of liver fibrosis effect is better.
【CateGory Index】: R575.2
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 6 Hits
1 TANG Ying-zi, CHEN Yao-kai, LIU Lin, DENG Guo-hong, WANG Yu-ming (Institute of Infectious Diseases, Southwest Hospital, Third Military Medical University, Chongqing 400038, China);Correlation factors involved in therapeutic efficacy of adefovir dipivoxil for chronic hepatitis B patients[J];Acta Academiae Medicinae Militaris Tertiae;2007-18
2 JIA Jidong, YIN Shanshan.Center of Liver Disease, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050,China;Diagnosis and treatment of liver fibrosis[J];Journal of Clinical Internal Medicine;2002-04
3 YU Xiaohui, ZHAO Liansan, ZHANG Xiuhui, TAN Mingzhen, WU Xiongzhi,XU Qian,MA Ying,XIONG ZhonghuaCenter of Infection Disenoe,Huaxi Hospital,Sichuan University,Chengdu 610041, China;Consistency of pathology and clinical diagnosis of chronic hepatitis B[J];Chinese Journal of Gastroenterology and Hepatology;2005-01
4 LU Lun-gen, ZENG Min-de. Department of Gastroenterology, Renji Hospital, Shanghai Institute of Digestive Diseases, Shanghai Second Medical University, Shanghai 200001, China;Diagnosis and evaluation of hepatic fibrosis[J];Chinese Journal of Hepatology;2005-08
5 HU Yi-yang;LIU Ping;LIU Cheng;LIU Cheng-hai;XU Lie-ming;Institute of Liver Diseases;Shanghai University of Traditional Chinese Medicine;Shanghai 201203, China;The value of serum markers in evaluating liver fibrotic changes[J];Chinese Journal of Hepatology;2006-03
6 LIU Jie*, WANG Ji-yao, LU Ye. *Department of Gastroenterology , Zhongshan Hospital, Fudan University, Shanghai 200032, China;Serum fibrosis markers in diagnosing liver fibrosis[J];Chinese Journal of Internal Medicine;2006-06
【Secondary Citations】
Chinese Journal Full-text Database 10 Hits
1 CHEN Yong-peng, ZHU You-fu, FENG Xiao-rong, PENG Jie, HOU Jin-linDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B[J];Journal of First Military Medical University;2004-10
2 Xu Xiping (Department of Infectious Disease, Second Affiliated Hospital, Hubei Medical University, Wuhan 430071, China);A Comparative Analysis of Pathological and Clinical Diagnosis in 47 Patients Died from Liver Disease[J];ACTA ACADEMIAE MEDICINAE HUBEI;1997-04
3 MA Hong-bo,LANG Zhen-wei,JIN Rui,et al.(Beijing You'an Hospital,Beijing 100054,China);Comparison analysis of the clinic parameter and the pathology in the patients with chronic hepatitis[J];Chinese Journal of Clinical Hepatology;2003-03
4 JIA Jidong, YIN Shanshan.Center of Liver Disease, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050,China;Diagnosis and treatment of liver fibrosis[J];Journal of Clinical Internal Medicine;2002-04
5 Gai Hongpeng (The No 6 Hospital of Dalian City in Liaoning Province, Dalian 116001);The Study of Diagnostic Value of Co-detection of Serum HA、LN and PCⅢ in the Liver Fibrosis[J];Clinical Medical Journal of China;2004-05
6 LIU Ping 1, HU Yi-Yang 1, LIU- Cheng 1, XU Lie-Ming 1, LIU Cheng-Hai 1, SUN Ke-Wei 2, HU De-Chang 3,YIN You-Kuan 3,ZHOU Xia-Qi u 4,WAN Mo-Bin 5, CAI Xiong 6, ZHANG Zhi-Qing 7,YE Jun 8, TANG Bao-Zhang 9,HE Jia 10 (1.Research Institute of Liver Diseases, Shanghai University of Traditional Chi nese Medicine,Shanghai 200032,China;2.Infectious Diseases Department,The Af filiated Hospital of Hunan College of Traditional Chinese Medicine,Changsha,Hun an Province 410007,China;3.Infectious Diseases Department,Zhongshan Hospital ,Fudan University,Shanghai 200032,China;4.Infectious Diseases Department,Ru ijin Hospital,Shanghai Second Medical University,Shanghai 200025,China;5.Infe ctious Diseases Department,Shanghai Changhai Hospital,Shanghai 200433,China;6 .Infectious Diseases Department,Shanghai Changzheng Hospital,Shanghai 200003, China;7.Infectious Diseases Department,The 4th People’s Hospital of Huai’an City,Huai’an, Jiangsu Province 223300,China;8.Infectious Diseases Departmen t,The Central Hospital of Putuo District, Shanghai 200062,China;9.Infectious Diseases Department,The Affiliated Hospital of Yunnan College of Traditional C hinese Medicine,Kunming, Yunnan Province 650200,China;10.Mathematical Statist ics Department,Second Military Medical University,Shanghai 200433,China);Multicenter clinical study about the action of Fuz heng Huayu Capsule against liver fibrosis with chronic hepatitis B[J];Journal of Chinese Integrative Medicine;2003-02
7 LUO Ruihong, YANG Shaoji, XIE Junqiang, et al. Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat-sen University of Medical Sciences, Guangzhou 510630, China;Diagnostic value of five serum markers for liver fibrosis[J];Chinese Journal of Hepatology;2001-03
8 LI Chengzhong, WAN Mobin, ZENG Minde, et al. Changhai Hospital, Second Military Medical University, Shanghai 200433, China [;A preliminary study of the combination of noninvasive parameters in the diagnosis of liver fibrosis[J];Chinese Journal of Hepatology;2001-05
9 DU Xinfang, WENG Honglei, CAI Weimin. Beilun Zongrui Hospital, Ningbo 315806, China [;Histological changes in 20 hepatic fibrosis patients with chronic hepatitis B after recombinant human interferon-γ treatment[J];Chinese Journal of Hepatology;2001-05
10 CAI Wei-min, TAO Jun, WENG Hong-lei, LIU Rong-hua. Institute of Infectious Diseases, the First Ajfiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China;Study on the influence factors of the serum flbrosis markers[J];Chinese Journal of Hepatology;2003-01
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved